Intracellular skeletal muscle glucose metabolism is differentially alteredby dexamethasone treatment of normoglycemic relatives of type 2 diabetic patients
Je. Henriksen et al., Intracellular skeletal muscle glucose metabolism is differentially alteredby dexamethasone treatment of normoglycemic relatives of type 2 diabetic patients, METABOLISM, 48(9), 1999, pp. 1128-1135
Young first-degree relatives of type 2 diabetic patients are insulin-resist
ant, with the insulin resistance mainly located in skeletal muscle due to d
ecreased insulin-induced nonoxidative glucose metabolism and muscle glycoge
n synthase activation. We investigated whether the mechanism differs for de
xamethasone (dex)-induced insulin resistance in first-degree relatives of t
ype 2 diabetics versus healthy control subjects by quantifying intracellula
r glucose processing in muscle biopsies taken before and after 5 days of de
x treatment (4 mg/d) in 20 normal glucose-tolerant relatives of type 2 diab
etic patients and 20 matched controls (age, 29.4 +/- 1.7 v 29.4 +/- 1.6 yea
rs; body mass index, 25.1 +/- 1.0 v 25.1 +/- 0.9 kg/m(2)). In addition, an
intravenous glucose tolerance test (IVGTT) combined with continuous indirec
t calorimetry was performed. Following 5 days of dex treatment, glucose tol
erance deteriorated in both the relatives and the control subjects, Fasting
dry-weight muscle glucose and fasting intracellular muscle glucose concent
rations increased in response to dex only in the relatives (2.43 +/- 0.21 v
2.97 +/- 0.26 mmol/kg dry weight, P < .05; 0.28 +/- 0.07 v 0.45 +/- 0.08 m
mol/L intracellular water, P < .05); no increases were observed in the cont
rol subjects. Fasting dry-weight muscle lactate also increased post-dex onl
y in the relatives (7.37 +/- 0.40 v 10.77 +/- 1.22 mmol/kg dry weight, P <
.001). Both basal muscle glucose and lactate concentrations from the IVGTT
study correlated with the 2-hour post-dex glucose value obtained during the
OGTT study in the relatives (R = .76 and R = .74, respectively, both P < .
0001) but not in the control subjects. Basal intramuscular glycogen synthas
e activity decreased approximately 25% in both the relatives and control su
bjects post-dex; the decrement was significant (P < .01) only in control su
bjects. Indirect calorimetry during the post-dex IVGTT demonstrated increas
ed glucose oxidation (P < .03) and reduced lipid oxidation (P < .03) in the
relatives only. We postulate that the insulin resistance induced by dex in
first-degree relatives of type 2 diabetic patients is associated with a pr
eferential channeling of glucose into the glycolytic pathway (increased glu
cose oxidation and lactate production), probably associated with a preexist
ing downregulation of the glycosen synthase pathway. Copyright(C) 1999 by W
.B. Saunders Company.